At AM-Pharma we work together in a constructive, collaborative and team-oriented way, towards achieving the company objectives without losing sight of our own objectives. We put the common interest of the company and the patient above our own individual interest.
AM-Pharma’s purpose is to save the lives of patients confronted with kidney disease, sepsis and organ injury. Our initial focus is sepsis-associated acute kidney injury, the cause of death for hundreds of thousands of people hospitalized each year. Our proprietary recombinant human alkaline phosphatase has the potential to become the first treatment specifically developed for sepsis-associated acute kidney injury and is now in a global pivotal Phase III clinical trial. We are a dedicated team driven to bring treatment options to severely ill patients, their families and acute care professionals.
AM-Pharma is a clinical stage biopharmaceutical company based in Utrecht, the Netherlands.
Our mission is to transform the treatment prospects for patients with kidney disease, sepsis and organ injury by developing and commercializing our recombinant alkaline phosphatase. Join us in fighting these devastating conditions.
INTERESTED IN A CAREER AT AM-PHARMA?
Details of current vacancies – if any – are listed on this page. To apply, please send your CV and cover letter, stating the title of the position you are applying for, to firstname.lastname@example.org.